Please login to the form below

Not currently logged in

UniQure skyrockets on haemophilia B gene therapy data

UniQureCompetition with Pfizer and Spark rival heats up

AI specialist Exscientia buys Kinetic Discovery

The biophysics tech will radically improve the drug discovery paradigm, says Exscientia

AZ drug matched to cancer mutation passes phase 2 test

AZ logoMore data from promising class of targeted small molecule drugs

Roche gains speedy review for Tecentriq in first-line breast cancer

TecentriqSet to become the first immunotherapy for triple negative breast cancer

Duchenne UK backs Evox dystrophin delivery project

EvoxFunding will drive preclinical studies on dystrophin-bearing exosomes

Gilead NASH drug clears mid-stage trial, but rivals are looming

GileadPositive results to challenge Intercept in emerging disease area

Novartis’ heart failure drug Entresto proves superior to enalapril

Novartis buildingResults could see the drug strengthen its position in the market

Soon-Shiong presents first data on cancer memory vaccine at SITC

NantkWestNovel cocktail shows modest gains in prostate cancer

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...